CareONE Concierge Now Accepting Candidates for Alzheimer's Device Study
ATLANTA, July 10, 2025 /PRNewswire/ — CareONE Concierge has announced the launch of a new research study to evaluate an innovative wearable device aimed at addressing cognitive symptoms associated with Alzheimer's-related dementia. The study will utilize NeuroEM Therapeutics'® TEMT-RF cap, a non-invasive device that has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA).
Alzheimer's disease is a growing global health crisis, affecting nearly 7 million Americans and is projected to impact nearly 13 million by 2050. Despite decades of research, treatment options remain limited, with most current therapies only addressing symptoms rather than the underlying causes of cognitive decline. NeuroEM Therapeutics is pioneering Transcranial Electromagnetic Treatment using Radio Frequencies (TEMT-RF) as a potentially groundbreaking approach to treating the disease at its root.
The lightweight, wearable device delivers electromagnetic waves similar to those produced by cell phone signals from multiple emitters. It is being investigated for its potential to break apart toxic protein oligomers within neurons throughout the brain. These oligomers—clusters of beta-amyloid and tau proteins—are thought to drive the progression of Alzheimer's disease. By disrupting these harmful accumulations, TEMT-RF may help restore neuronal function and slow cognitive decline.
'We all know friends and family members who have been impacted by Alzheimer's or dementia,' said Peter Bechtel, CEO of CareONE Concierge. 'This study represents a potential turning point in the fight against these devastating conditions. By participating in this study, individuals have the opportunity to experience cutting-edge, non-drug therapy while contributing to groundbreaking advancements in Alzheimer's treatment.'
This study is independently conducted by CareONE Concierge and is designed for individuals with mild to moderate Alzheimer's-related dementia. Participants will be required to wear the device twice daily for one hour, follow a structured research protocol, and complete cognitive assessments throughout the study.
Dr. Edward Goodwin, Chief Scientist at NeuroEM, emphasized the scientific foundation behind TEMT-RF, stating, 'Our research has shown that TEMT-RF has the potential to impact the key biological processes associated with Alzheimer's disease. This study will help us gather more real-world data on how the device affects cognitive function and overall brain health.'
'NeuroEM is excited to partner with CareONE Concierge,' stated Chuck Papageorgiou, CEO of NeuroEM Therapeutics. 'Our objective is to promote safe, effective, and non-invasive technologies for cognitive health, and research initiatives like this are essential in helping us uncover the full potential of TEMT-RF. With Alzheimer's cases increasing, innovative research such as this provides new hope for patients, caregivers, and the future of cognitive health. Together, we can take meaningful steps toward a future where memory loss is no longer an inevitable part of aging.'
CareONE Concierge is now accepting qualified participants for the study. For more information or to apply, please email CT@careone-concierge.com or apply at www.BestMindForMe.com.
About CareONE ConciergeCareONE Concierge is committed to delivering Preventative Healthcare solutions that meet the needs of patients, providers, and the healthcare system. The company works with physicians, patients, and healthcare systems to develop turnkey solutions that increase patient outcomes while enhancing revenue and quality metrics. To learn more, visit www.careone-concierge.com .
About NeuroEM Therapeutics®NeuroEM Therapeutics is leading the way in the development and clinical testing of bioengineered technology to reverse the cognitive decline associated with Alzheimer's disease and other neurodegenerative conditions. Built upon a decade of groundbreaking research conducted at Tampa-based research facilities at the University of South Florida (USF), the company received the first Breakthrough Device status from the U.S. Food and Drug Administration (FDA) to treat Alzheimer's disease. NeuroEM's continued dedication to cutting-edge research is bringing to market a first-in-class wearable device designed for in-home use to extend healthy longevity using patented Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF) technology. To learn more, visit neuroem.com.
Media Contact:Wendy Stevens, Study Manager(919) 600-9930wstevens@careone-concierge.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
5 hours ago
- The Sun
Trump's AG drops COVID vaccine fraud case involving Utah doctor
WASHINGTON: US Attorney General Pam Bondi has dismissed a fraud case against a Utah doctor accused of falsifying COVID-19 vaccination certificates and destroying government-provided vaccines worth over $28,000. The decision, announced on social media platform X, stated that Dr Michael Kirk Moore Jr did not deserve the prison sentence he faced. Moore, indicted by a federal grand jury in 2023, had begun trial earlier this month. Bondi defended the dismissal, saying, 'Dr Moore gave his patients a choice when the federal government refused to do so. He did not deserve the years in prison he was facing. It ends today.' The case has drawn attention amid broader debates over vaccine mandates. The Trump administration has supported vaccine skeptics, including efforts to reinstate military personnel discharged for refusing COVID-19 vaccinations. Health Secretary Robert F Kennedy Jr, a vocal critic of vaccine policies, praised Moore in April, calling him a 'hero' for his defiance. According to a 2023 statement from the US Attorney's Office in Utah, Moore allegedly issued fake vaccine certificates from a plastic surgery center. Prosecutors claimed he administered saline shots to minors, misleading them into believing they had received COVID-19 vaccines at their parents' request. Georgia lawmaker Marjorie Taylor Greene, a prominent Trump ally, celebrated the case's dismissal, calling Moore a hero and warning against government overreach. 'We can never again allow our government to turn tyrannical under our watch,' she posted on X. Bondi's decision follows controversy over her removal of senior Justice Department officials involved in Trump-related investigations, raising concerns about political interference in federal law enforcement. - Reuters
Malaysian Reserve
a day ago
- Malaysian Reserve
14 Top Press Releases from June
Including Michaels acquiring JOANN, top university rankings, and seasonal news from both Whataburger and Spirit Halloween. NEW YORK, July 11, 2025 /PRNewswire/ — With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help journalists and consumers stay on top of the month's most newsworthy and popular releases, here's a recap of some major stories from the last month that shouldn't be missed. The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download. The Michaels Companies, Inc. Acquires JOANN® Intellectual Property and Private Label Brands'This acquisition allows us to better serve both new and existing customers, respond to rising demand across categories, and build on our momentum as the destination for creating and celebrating in North America,' said David Boone, Chief Executive Officer at Michaels. U.S. News Releases 2025-2026 Best Global Universities RankingsOf the 51 subject rankings, eight will have more schools ranked this year, including: agricultural sciences; artificial intelligence; computer science; electrical and electronic engineering; engineering; gastroenterology and hepatology; plant and animal science and polymer science. Drink Up, Collect 'Em All – Whataburger Releases Limited-Edition Commemorative CupsEach collection is a tribute to Whataburger's history, holidays and downright delicious favorites. Expect iconic Whataburger themes, some festive fun for Halloween and Christmas, plus something a little extra special for National Whataburger Day. These aren't just cups – they're keepsakes. Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing'Novo Nordisk is firm on our position and protecting patients living with obesity. When patients are prescribed semaglutide treatments by their licensed healthcare professional or a telehealth provider, they are entitled to receive authentic, FDA-approved and regulated Wegovy®,' said Dave Moore, Executive Vice President, US Operations of Novo Nordisk Inc. Chainlink and Mastercard Partner to Enable Over 3 Billion Cardholders to Purchase Crypto Directly OnchainAs adoption of crypto assets continues to grow, collaborations like the one between Mastercard and Chainlink are helping drive a new wave of user-centric solutions that bridge the gap between crypto-native technology and real-world usability. BOXABL Announces Intent to Merge with a SPAC, Targeting Nasdaq ListingThe Proposed Transaction represents a significant step forward in BOXABL's mission to revolutionize affordable, sustainable housing. BOXABL currently has over 50,000 investors, representing an aggregate investment of over $200 million, who have shown support for BOXABL's mission and vision. Hunting for a Job? Spirit Halloween Hiring 50,000 Retail Associates for 2025 SeasonSpirit Halloween treats associates to frightfully fun perks, including competitive salaries, flexible scheduling, a premium pay incentive program, and seasonal retention bonuses for returning store managers. To keep the tricks and treats alive after-hours, all associates also receive a 30% discount on Spirit Halloween purchases. Clarivate Unveils the 2025 Journal Citation ReportsThis is the 50th anniversary of the industry-leading annual reports, which provide a comprehensive overview of the world's leading and trusted academic journals, offering academic institutions, researchers, and publishers the ability to gauge journals' trustworthiness and impact. Big4Bio and BYTE51 Announce Partnership at 2025 BIO International Convention to Make Life Sciences Intelligence Accessible to AllStarting June 16, Big4Bio subscribers can access BYTE51 for just $1,198 per year, compared to the standard $2,500 annual price. This discounted rate opens the door to a level of biotech market intelligence that might otherwise cost up to $20,000 per year through legacy data providers. The Princeton Review Has Posted Its 'Best Value Colleges for 2025' Report: Top Public and Private Colleges Ranked in Seven CategoriesThe criteria for the school selections broadly cover three subjects: academics, affordability, and career outcomes for graduates. More than 40 data points from the survey of administrators as well as surveys of students and of alumni were analyzed in the selection process. Fortune Announces 2025 Fortune 500 ListWalmart earned the top spot on the Fortune 500 list for the 13th straight year, generating more than $7 trillion in cumulative revenue over that time period, followed by Amazon, UnitedHealth Group, Apple, and CVS Health. The top 10 Fortune 500 companies generated over $290 billion in annual revenue, totaling $4.2 trillion. Carnival Cruise Line to Launch New Loyalty Program in 2026 Dubbed 'Carnival Rewards'™A cruise industry first, the program will introduce a points-based system featuring personalized perks and new ways to earn status, including credit card spend. Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular riskVerve is developing a pipeline of gene editing medicines designed to address the drivers of atherosclerotic cardiovascular disease (ASCVD) through treatments that may only need to be given once in a lifetime. ADP National Employment Report: Private Sector Employment Increased by 37,000 Jobs in May; Annual Pay was Up 4.5%'After a strong start to the year, hiring is losing momentum,' said Dr. Nela Richardson, chief economist, ADP. 'Pay growth, however, was little changed in May, holding at robust levels for both job-stayers and job-changers.' Read more of the latest releases from PR Newswire. Trending Topics In addition to the newsworthy headlines above, the PR Newswire team spotted several larger trending topics dominating headlines in June: Summer Entertaining: Whether consumers were hosting a barbecue, attending a concert, hitting the beach or embracing the latest style, there was something for everyone in June. Whataburger debuted its line of Whatafresher beverages, while Peroni made the jump to frozen treats to help consumers stay cool. The releases also kept pet parents in mind, with summer pet safety tips from TurfMutt and Swimply's new way to help dogs cool off in the pool. Other releases ranged from summer injury prevention tips to a Baby Shark x SHEIN summer collection, festive foil for summer barbecues and summer blockbuster partnerships. Pride Month: Brands shared updates on recent legislation, events and campaigns related to and celebrating the LGBTQ+ community. HBO Max releases its GAY HBO MAX SONG by drag superstar and DJ Trixie Mattel and Häagen-Dazs® celebrated three LGBTQIA2+S artists with large-scale murals. Meanwhile, brands reacted to the elimination of the 988 Suicide and Crisis Lifeline, which serves LGBTQ+ youth and young adults. And the National Press Club Journalism Institute hosted a discussion on localizing LGBTQ+ stories for communities nationwide. Father's Day: Companies shared their love for dads with press releases covering gift ideas, special events, men's health awareness and more. There were of course grilling recipes, but other releases shared the launch of Snoop Dogg's new direct-to-consumer e-commerce platform with a special Father's Day promotion and the kick off of the KIDZ BOP 'Daddy Dance Off.' Men's health issues, from cholesterol to postpartum depression, were also a focus of Father's Day-related announcements. Coming up: The Fourth of July may already be behind us, but our team expects summer-related news to continue showing up in press releases as the season progresses, whether it be in travel, food or the entertainment industry. Both International Self Care Day (July 24) and back-to-school season typically generate a wave of headlines, so we'll be on the lookout for related stories. And with earnings season kicking off in mid-July, the wire will be full of companies' latest financial results. Do you have a press release to distribute? Sign up with PR Newswire to share your story with the audiences who matter most. Helping Journalists Stay Up to Date on Industry News These are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists. Once they're signed up, reporters, bloggers, and freelancers have access to the following free features: Customization: Users can create customized newsfeeds that will deliver relevant news right to their inbox. Newsfeed results can be targeted by keywords, industry, subject, geography, and more. Photos and Videos: Thousands of multimedia assets are available to download and include in a journalist or blogger's next story. Subject Matter Experts: Journalists will have access to ProfNet, a database of industry experts to connect with as sources or for quotes in their articles. Related Resources: Our journalist- and blogger-focused blog, Beyond Bylines, features regular media news roundups, writing tips, upcoming events, and more. About PR Newswire PR Newswire is the industry's leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world. For questions, contact the team at
Malaysian Reserve
3 days ago
- Malaysian Reserve
CareONE Concierge Now Accepting Candidates for Alzheimer's Device Study
Study offers patients the opportunity to try an experimental, non-drug therapy for Alzheimer's using an FDA-designated Breakthrough Device ATLANTA, July 10, 2025 /PRNewswire/ — CareONE Concierge has announced the launch of a new research study to evaluate an innovative wearable device aimed at addressing cognitive symptoms associated with Alzheimer's-related dementia. The study will utilize NeuroEM Therapeutics'® TEMT-RF cap, a non-invasive device that has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). Alzheimer's disease is a growing global health crisis, affecting nearly 7 million Americans and is projected to impact nearly 13 million by 2050. Despite decades of research, treatment options remain limited, with most current therapies only addressing symptoms rather than the underlying causes of cognitive decline. NeuroEM Therapeutics is pioneering Transcranial Electromagnetic Treatment using Radio Frequencies (TEMT-RF) as a potentially groundbreaking approach to treating the disease at its root. The lightweight, wearable device delivers electromagnetic waves similar to those produced by cell phone signals from multiple emitters. It is being investigated for its potential to break apart toxic protein oligomers within neurons throughout the brain. These oligomers—clusters of beta-amyloid and tau proteins—are thought to drive the progression of Alzheimer's disease. By disrupting these harmful accumulations, TEMT-RF may help restore neuronal function and slow cognitive decline. 'We all know friends and family members who have been impacted by Alzheimer's or dementia,' said Peter Bechtel, CEO of CareONE Concierge. 'This study represents a potential turning point in the fight against these devastating conditions. By participating in this study, individuals have the opportunity to experience cutting-edge, non-drug therapy while contributing to groundbreaking advancements in Alzheimer's treatment.' This study is independently conducted by CareONE Concierge and is designed for individuals with mild to moderate Alzheimer's-related dementia. Participants will be required to wear the device twice daily for one hour, follow a structured research protocol, and complete cognitive assessments throughout the study. Dr. Edward Goodwin, Chief Scientist at NeuroEM, emphasized the scientific foundation behind TEMT-RF, stating, 'Our research has shown that TEMT-RF has the potential to impact the key biological processes associated with Alzheimer's disease. This study will help us gather more real-world data on how the device affects cognitive function and overall brain health.' 'NeuroEM is excited to partner with CareONE Concierge,' stated Chuck Papageorgiou, CEO of NeuroEM Therapeutics. 'Our objective is to promote safe, effective, and non-invasive technologies for cognitive health, and research initiatives like this are essential in helping us uncover the full potential of TEMT-RF. With Alzheimer's cases increasing, innovative research such as this provides new hope for patients, caregivers, and the future of cognitive health. Together, we can take meaningful steps toward a future where memory loss is no longer an inevitable part of aging.' CareONE Concierge is now accepting qualified participants for the study. For more information or to apply, please email CT@ or apply at About CareONE ConciergeCareONE Concierge is committed to delivering Preventative Healthcare solutions that meet the needs of patients, providers, and the healthcare system. The company works with physicians, patients, and healthcare systems to develop turnkey solutions that increase patient outcomes while enhancing revenue and quality metrics. To learn more, visit . About NeuroEM Therapeutics®NeuroEM Therapeutics is leading the way in the development and clinical testing of bioengineered technology to reverse the cognitive decline associated with Alzheimer's disease and other neurodegenerative conditions. Built upon a decade of groundbreaking research conducted at Tampa-based research facilities at the University of South Florida (USF), the company received the first Breakthrough Device status from the U.S. Food and Drug Administration (FDA) to treat Alzheimer's disease. NeuroEM's continued dedication to cutting-edge research is bringing to market a first-in-class wearable device designed for in-home use to extend healthy longevity using patented Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF) technology. To learn more, visit Media Contact:Wendy Stevens, Study Manager(919) 600-9930wstevens@
